Research Letter

Maternal exposure to statins and risk for birth defects: A case-series approach†‡§

  1. Emily E. Petersen1,2,
  2. Allen A. Mitchell3,
  3. John C. Carey4,
  4. Martha M. Werler3,
  5. Carol Louik3,
  6. Sonja A. Rasmussen1,*

Article first published online: 15 SEP 2008

DOI: 10.1002/ajmg.a.32493

Issue

American Journal of Medical Genetics Part A

American Journal of Medical Genetics Part A

Volume 146A, Issue 20, pages 2701–2705, 15 October 2008

Additional Information

How to Cite

Petersen, E. E., Mitchell, A. A., Carey, J. C., Werler, M. M., Louik, C. and Rasmussen, S. A. (2008), Maternal exposure to statins and risk for birth defects: A case-series approach. Am. J. Med. Genet., 146A: 2701–2705. doi: 10.1002/ajmg.a.32493

Author Information

  1. 1

    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia

  2. 2

    The CDC Experience Fellowship, Atlanta, Georgia

  3. 3

    Slone Epidemiology Center at Boston University, Boston, Massachusetts

  4. 4

    Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, Utah

*National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Road, MS E-86, Atlanta, GA 30333.

  1. †

    This article is a US Government work and, as such, is in the public domain in the United States of America.

  2. ‡

    The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

  3. §

    Following completion of this manuscript, Dr. Mitchell was approached by Merck and served as a consultant regarding an assessment of statin safety in pregnancy.

  4. How to cite this article: Petersen EE, Mitchell AA, Carey JC, Werler MM, Louik C, Rasmussen SA, the National Birth Defects Prevention Study. 2008. Maternal exposure to statins and risk for birth defects: A case-series approach. Am J Med Genet Part A 146A:2701–2705.

Publication History

  1. Issue published online: 24 SEP 2008
  2. Article first published online: 15 SEP 2008
  3. Manuscript Accepted: 24 JUN 2008
  4. Manuscript Received: 31 AUG 2007

Funded by

  • National Institute of Child Health and Human Development. Grant Number: HD27697
  • National Heart, Lung, and Blood Institute. Grant Number: HL 50763
  • Massachusetts Center for Birth Defects Research and Prevention, Massachusetts Department of Public Health
  • Aventis, Inc.
  • Sanofi Pasteur, Inc.
  • GlaxoSmithKline
  • CDC Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (58K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (58K)